Literature DB >> 1860169

Activation of c-K-ras is frequent in pancreatic carcinomas of Syrian hamsters, but is absent in pancreatic tumors of rats.

H J van Kranen1, E Vermeulen, L Schoren, J Bax, R A Woutersen, P van Iersel, C F van Kreijl, E Scherer.   

Abstract

We have investigated the presence of mutations in ras genes at codons 12, 13 and 61 in chemically induced pancreatic tumors of rats and Syrian hamsters. Mutations were detected by means of allele-specific oligonucleotide hybridization to ras sequences amplified in vitro by the polymerase chain reaction. No mutations were observed in the c-K-ras gene or the c-H-ras gene of nine azaserine-induced adenomas and 15 carcinomas of the rat pancreas. This indicates that activated ras genes are not commonly involved in rat pancreatic cancer evolving from acinar cells. However, in 19 out of 20 ductular adenocarcinomas of hamster pancreas (95%), either codon 12 or 13 of the c-K-ras gene was mutated. This indicates that the activation of c-K-ras is a frequent event in the multistep process of pancreatic carcinogenesis induced by the alkylating carcinogen N-nitrosobis(2-oxopropyl)amine (BOP). The mutations of both codons were G----A transitions of the second base which is consistent with the type of mutation to be expected from DNA alkylation. Activation of the c-K-ras gene, therefore, may not only be a frequent but also an early event in hamster pancreas carcinogenesis. The frequent activation of the c-K-ras gene in both human and hamster pancreatic cancer emphasizes the relevance of BOP-induced pancreatic adenocarcinomas in Syrian hamsters as an experimental model system for studying human pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1860169     DOI: 10.1093/carcin/12.8.1477

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  10 in total

1.  Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.

Authors:  S T Dergham; M C Dugan; R Kucway; W Du; D S Kamarauskiene; V K Vaitkevicius; J D Crissman; F H Sarkar
Journal:  Int J Pancreatol       Date:  1997-04

Review 2.  On the role of cholecystokinin in pancreatic cancer.

Authors:  M K Herrington; T E Adrian
Journal:  Int J Pancreatol       Date:  1995-04

3.  Investigational Strategies for Detection and Intervention in Early-Stage Pancreatic Cancer. April 24-27, Annapolis, Maryland. Abstracts.

Authors: 
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

4.  K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines.

Authors:  N Erill; M Cuatrecasas; F J Sancho; A Farré; P M Pour; F Lluís; G Capellá
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

5.  Modification of blood group A expression in human pancreatic tumor cell lines by inhibitors of N-glycan processing.

Authors:  C Schaffert; P M Pour; W G Chaney
Journal:  Int J Pancreatol       Date:  1997-02

Review 6.  K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.

Authors:  R H Hruban; A D van Mansfeld; G J Offerhaus; D H van Weering; D C Allison; S N Goodman; T W Kensler; K K Bose; J L Cameron; J L Bos
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

7.  Proliferative heterogeneity of human renal cell carcinomas and prevalence of ras gene point mutations.

Authors:  V Waldmann; H M Rabes
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 8.  Experimental pancreatic hyperplasia and neoplasia: effects of dietary and surgical manipulation.

Authors:  P Watanapa; R C Williamson
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

Review 9.  Recent results in animal models of pancreatic carcinoma: histogenesis of tumors.

Authors:  D S Longnecker; V Memoli; O S Pettengill
Journal:  Yale J Biol Med       Date:  1992 Sep-Oct

10.  Experimental animal models of pancreatic carcinogenesis for prevention studies and their relevance to human disease.

Authors:  Mami Takahashi; Mika Hori; Michihiro Mutoh; Keiji Wakabayashi; Hitoshi Nakagama
Journal:  Cancers (Basel)       Date:  2011-02-09       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.